1. Main page
  2. Biotechnology
  3. NantKwest

NantKwest

3 Decision Makers · 4 Verified Contacts & Email Format

nantkwest.com
📍 San Diego, CABiotechnology🗓 Est. 2002👥 51–100 employees

About NantKwest

NantKwest is a clinical-stage immunotherapy company focused on harnessing the immune system to treat disease.

Email Format

{first_name}.{last_name}@nantkwest.com — 100.0%

sarah.smith@nantkwest.com

Leadership & Decision Makers

Contact details of 3 NantKwest decision makers

Frances Toneguzzo

Executive Vice President

Barry Simon

President and COO

Patrick Soon-Shiong

Executive Chairman & CEO

Team & Specialists

Contact details of 1 NantKwest team members

Hans Klingemann

  • Work email

    h*************n@nantkwest.com

General Emails

General company emails, e.g. customer support lines

    contact@conkwest.com

    General Inquiries

    contact@nantkwest.com

    General Inquiries

    hans.klingemann@nantkwest.com

    Unclassified inbox

Verify NantKwest Emails

Similar Companies like NantKwest

Sorrento Therapeutics

sorrentotherapeutics.com
Pharmaceuticals · San Diego, CA · Est. 2006 · 101–250 employees · $500M–$1B

HQ: San Diego, CA

Jazz Pharmaceuticals

jazzpharma.com
Biotechnology · Palo Alto, CA · Est. 2003 · 501–1000 employees · $500M–$1B

HQ: Palo Alto, CA

Moderna

modernatx.com
Biotechnology · Cambridge, MA · Est. 2010 · 1001–5000 employees

HQ: Cambridge, MA

Seagen

seagen.com
Biotechnology · Bothell, Washington, United States · Est. 1998 · 1001–5000 employees · $500M–$1B

HQ: Bothell, Washington, United States

Vertex Pharmaceuticals

vrtx.com
Biotechnology · Boston, MA · Est. 1989 · 1001–5000 employees · $500M–$1B

HQ: Boston, MA

Explore similar firms in the Biotechnology sector

Company Info

Last updated: 27/07/2025

nantkwest.com

(858)633-0300

San Diego, CA

Legal Name: Conkwest, Inc.
Business Type: Public
Employees: 51-100
Rounds: Post-IPO Equity
Founded Date: 2002
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:NK
Operating Status: Closed
Last Funding Type: Post-IPO Equity
Phone Number: (858)633-0300
Sub-Organization of: NantWorks
Last Investment Activity: Jul 26, 2021
Investments Activity: Jul 26, 2021 Mar 15, 2021 Mar 10, 2021

Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.